3190 results for «622»

Filter By

3190 results

Which valve for which patient? - Part 2: complex anatomy

17 May 2023 – From EuroPCR 2023

Consult this session if you want to understand how to optimize the hemodynamic performance after VinV procedures, to identify patients at risk for coronary occlusion and how to prevent this in VinV procedures, and to learn how to gain safe vascular access in challenging peripheral anatomies.

Which valve for which

Left main and bifurcation stenting: brainstorm and solutions in complicated cases

17 May 2023 – From EuroPCR 2023

Join this session to gain valuable insights into crisis treatment during unforeseen circumstances, acquire expert techniques for managing complex left main and bifurcation PCI, and explore practical strategies for managing left main lesions in STEMI through the analysis of three case presentations. Don't miss this opportunity...

Left main and bifurcation stenting: brainstorm and solutions in complicated cases

MINOCA to STEMI, a wild world

17 May 2023 – From EuroPCR 2023

Consult this session if you want to learn about the right diagnostic strategy, to understand the physiopathological mechanisms of some MINOCA, and to learn about possible therapeutic strategies.

MINOCA to STEMI, a wild world

Transcatheter tricuspid valve interventions

17 May 2023 – From EuroPCR 2023

Consult this session if you want to understand clinical scenarios associated with tricuspid regurgitation, to learn the state of the art in devices and indications to treat tricuspid regurgitation, and to deepen into the available evidence of outcomes of different therapies for tricuspid regurgitation.

Transcatheter tricuspid valve interventions

Complex bifurcation PCI - LIVE case

17 May 2023 – From EuroPCR 2023

Study the case of this 69-year-old male patient with recent PCI on LAD presenting chronic coronary syndrome. Angiography showed calcified stenosis on bifurcation of proximal CX and large obtuse marginal 1, Medina 0-1-1.

The PCI strategy was an OCT-guided TAP technique: 

7F guiding catheter, predilatation with semi-compliant and non-compliant...

Complex bifurcation PCI - LIVE case

SOLACI research - Developing original research across Latin America

17 May 2023 – From EuroPCR 2023

In these slides, get an insight into real-world bifurcation lesion management in Latin America, diverse STEMI reperfusion access in this region, and limitations to widespread TAVI adoption, along with the Latin America TAVI guidelines.

SOLACI research - Developing original research across Latin America

Transcatheter tricuspid valve replacement - LIVE case

15 May 2024 – From EuroPCR 2024

An 82-year-old male with a history of STEMI in 2013, stroke in 2018, cancer, and permanent AF, presented with acute heart failure with predominant right-side failure. Severe tricuspid regurgitation was identified.
The operators implanted an Evoque valve percutaneously under TEE guidance and general anaesthesia via the venous...

Transcatheter tricuspid valve replacement

Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

29 Mar 2025

Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.

Author

Aaysha Cader
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

22 Mar 2022

Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022. 

Daniele Giacoppo

Author

Daniele Giacoppo
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial

07 Apr 2024

REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.

Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...

Nicola Ryan

Author

Nicola Ryan

Author

Ali Nazmi Calik
REDUCE-AMI: Long-term beta-blocker treatment after AMI and preserved LVEF
Didn’t find what you were looking for?